(CCI) Crown Castle - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US22822V1017
Stock: Towers, Fiber, Small Cells, Infrastructure
Total Rating 29
Risk 26
Buy Signal -0.79
| Risk 5d forecast | |
|---|---|
| Volatility | 28.6% |
| Relative Tail Risk | -2.05% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.00 |
| Alpha | -3.42 |
| Character TTM | |
|---|---|
| Beta | -0.007 |
| Beta Downside | -0.012 |
| Drawdowns 3y | |
|---|---|
| Max DD | 34.21% |
| CAGR/Max DD | -0.18 |
EPS (Earnings per Share)
Revenue
Description: CCI Crown Castle March 05, 2026
Crown Castle (NYSE: CCI) operates as a Real Estate Investment Trust (REIT) in the telecommunications infrastructure sector.
The companys core business involves owning, operating, and leasing shared communications infrastructure. This includes approximately 40,000 cell towers and 90,000 route miles of fiber optic cable, which support small cells and fiber solutions.
This infrastructure is deployed across major U.S. markets, providing connectivity for data, technology, and wireless services. The telecom tower sector benefits from ongoing demand for wireless data and 5G expansion.
To deepen your understanding of CCIs financial health and market position, consider exploring its detailed analytics on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 444.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA 3.86 > 1.0 |
| NWC/Revenue: -78.19% < 20% (prev -19.68%; Δ -58.51% < -1%) |
| CFO/TA 0.10 > 3% & CFO 3.06b > Net Income 444.0m |
| Net Debt (29.30b) to EBITDA (2.77b): 10.59 < 3 |
| Current Ratio: 0.26 > 1.5 & < 3 |
| Outstanding Shares: last quarter (437.0m) vs 12m ago 0.69% < -2% |
| Gross Margin: 66.07% > 18% (prev 0.73%; Δ 6534 % > 0.5%) |
| Asset Turnover: 13.28% > 50% (prev 16.87%; Δ -3.59% > 0%) |
| Interest Coverage Ratio: 2.17 > 6 (EBITDA TTM 2.77b / Interest Expense TTM 959.0m) |
Altman Z'' -2.98
| A: -0.11 (Total Current Assets 1.14b - Total Current Liabilities 4.48b) / Total Assets 31.52b |
| B: -0.64 (Retained Earnings -20.16b / Total Assets 31.52b) |
| C: 0.06 (EBIT TTM 2.08b / Avg Total Assets 32.13b) |
| D: -0.61 (Book Value of Equity -20.16b / Total Liabilities 33.15b) |
| Altman-Z'' Score: -2.98 = D |
Beneish M 0.80
| DSRI: 5.20 (Receivables 2.63b/654.0m, Revenue 4.26b/5.52b) |
| GMI: 1.11 (GM 66.07% / 73.38%) |
| AQI: 1.87 (AQ_t 0.59 / AQ_t-1 0.32) |
| SGI: 0.77 (Revenue 4.26b / 5.52b) |
| TATA: -0.08 (NI 444.0m - CFO 3.06b) / TA 31.52b) |
| Beneish M-Score: 0.80 (Cap -4..+1) = D |
What is the price of CCI shares?
As of March 06, 2026, the stock is trading at USD 90.11 with a total of 3,593,526 shares traded.
Over the past week, the price has changed by +4.29%, over one month by +14.98%, over three months by +2.12% and over the past year by +0.13%.
Over the past week, the price has changed by +4.29%, over one month by +14.98%, over three months by +2.12% and over the past year by +0.13%.
Is CCI a buy, sell or hold?
Crown Castle has received a consensus analysts rating of 3.71.
Therefor, it is recommend to hold CCI.
- StrongBuy: 6
- Buy: 3
- Hold: 12
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the CCI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 98.9 | 9.8% |
| Analysts Target Price | 98.9 | 9.8% |
CCI Fundamental Data Overview March 05, 2026
P/E Trailing = 35.5354
P/E Forward = 31.25
P/S = 9.2307
P/B = 8.8551
P/EG = 0.8006
Revenue TTM = 4.26b USD
EBIT TTM = 2.08b USD
EBITDA TTM = 2.77b USD
Long Term Debt = 21.55b USD (from longTermDebt, last quarter)
Short Term Debt = 3.05b USD (from shortTermDebt, last quarter)
Debt = 29.57b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 29.30b USD (from netDebt column, last quarter)
Enterprise Value = 68.83b USD (39.36b + Debt 29.57b - CCE 99.0m)
Interest Coverage Ratio = 2.17 (Ebit TTM 2.08b / Interest Expense TTM 959.0m)
EV/FCF = 23.94x (Enterprise Value 68.83b / FCF TTM 2.88b)
FCF Yield = 4.18% (FCF TTM 2.88b / Enterprise Value 68.83b)
FCF Margin = 67.41% (FCF TTM 2.88b / Revenue TTM 4.26b)
Net Margin = 10.41% (Net Income TTM 444.0m / Revenue TTM 4.26b)
Gross Margin = 66.07% ((Revenue TTM 4.26b - Cost of Revenue TTM 1.45b) / Revenue TTM)
Gross Margin QoQ = 42.07% (prev 73.88%)
Tobins Q-Ratio = 2.18 (Enterprise Value 68.83b / Total Assets 31.52b)
Interest Expense / Debt = 0.84% (Interest Expense 249.0m / Debt 29.57b)
Taxrate = 1.07% (3.00m / 280.0m)
NOPAT = 2.06b (EBIT 2.08b * (1 - 1.07%))
Current Ratio = 0.26 (Total Current Assets 1.14b / Total Current Liabilities 4.48b)
Debt / Equity = -18.08 (negative equity) (Debt 29.57b / totalStockholderEquity, last quarter -1.64b)
Debt / EBITDA = 10.59 (Net Debt 29.30b / EBITDA 2.77b)
Debt / FCF = 10.19 (Net Debt 29.30b / FCF TTM 2.88b)
Total Stockholder Equity = -1.44b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.38% (Net Income 444.0m / Total Assets 31.52b)
RoE = -30.82% (negative equity) (Net Income TTM 444.0m / Total Stockholder Equity -1.44b)
RoCE = 10.33% (EBIT 2.08b / Capital Employed (Equity -1.44b + L.T.Debt 21.55b))
RoIC = 8.98% (NOPAT 2.06b / Invested Capital 22.89b)
WACC = 3.63% (E(39.36b)/V(68.93b) * Re(5.73%) + D(29.57b)/V(68.93b) * Rd(0.84%) * (1-Tc(0.01)))
Discount Rate = 5.73% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 81.65 | Cagr: 0.35%
[DCF] Terminal Value 87.09% ; FCFF base≈2.41b ; Y1≈2.61b ; Y5≈3.25b
[DCF] Fair Price = 152.9 (EV 95.98b - Net Debt 29.30b = Equity 66.69b / Shares 436.1m; r=5.90% [WACC]; 5y FCF grow 9.41% → 2.90% )
EPS Correlation: -36.83 | EPS CAGR: -10.87% | SUE: 0.02 | # QB: 0
Revenue Correlation: -78.06 | Revenue CAGR: -12.14% | SUE: 0.04 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.46 | Chg7d=+0.018 | Chg30d=+0.457 | Revisions Net=+1 | Analysts=4
EPS current Year (2026-12-31): EPS=2.35 | Chg7d=-0.008 | Chg30d=-1.055 | Revisions Net=-3 | Growth EPS=-6.6% | Growth Revenue=-5.2%
EPS next Year (2027-12-31): EPS=2.80 | Chg7d=-1.002 | Chg30d=-1.177 | Revisions Net=-3 | Growth EPS=+19.0% | Growth Revenue=+1.5%
[Analyst] Revisions Ratio: +1.00 (1 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 5.1% (Discount Rate 7.9% - Earnings Yield 2.8%)
[Growth] Growth Spread = -11.6% (Analyst -6.5% - Implied 5.1%)
P/E Forward = 31.25
P/S = 9.2307
P/B = 8.8551
P/EG = 0.8006
Revenue TTM = 4.26b USD
EBIT TTM = 2.08b USD
EBITDA TTM = 2.77b USD
Long Term Debt = 21.55b USD (from longTermDebt, last quarter)
Short Term Debt = 3.05b USD (from shortTermDebt, last quarter)
Debt = 29.57b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 29.30b USD (from netDebt column, last quarter)
Enterprise Value = 68.83b USD (39.36b + Debt 29.57b - CCE 99.0m)
Interest Coverage Ratio = 2.17 (Ebit TTM 2.08b / Interest Expense TTM 959.0m)
EV/FCF = 23.94x (Enterprise Value 68.83b / FCF TTM 2.88b)
FCF Yield = 4.18% (FCF TTM 2.88b / Enterprise Value 68.83b)
FCF Margin = 67.41% (FCF TTM 2.88b / Revenue TTM 4.26b)
Net Margin = 10.41% (Net Income TTM 444.0m / Revenue TTM 4.26b)
Gross Margin = 66.07% ((Revenue TTM 4.26b - Cost of Revenue TTM 1.45b) / Revenue TTM)
Gross Margin QoQ = 42.07% (prev 73.88%)
Tobins Q-Ratio = 2.18 (Enterprise Value 68.83b / Total Assets 31.52b)
Interest Expense / Debt = 0.84% (Interest Expense 249.0m / Debt 29.57b)
Taxrate = 1.07% (3.00m / 280.0m)
NOPAT = 2.06b (EBIT 2.08b * (1 - 1.07%))
Current Ratio = 0.26 (Total Current Assets 1.14b / Total Current Liabilities 4.48b)
Debt / Equity = -18.08 (negative equity) (Debt 29.57b / totalStockholderEquity, last quarter -1.64b)
Debt / EBITDA = 10.59 (Net Debt 29.30b / EBITDA 2.77b)
Debt / FCF = 10.19 (Net Debt 29.30b / FCF TTM 2.88b)
Total Stockholder Equity = -1.44b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.38% (Net Income 444.0m / Total Assets 31.52b)
RoE = -30.82% (negative equity) (Net Income TTM 444.0m / Total Stockholder Equity -1.44b)
RoCE = 10.33% (EBIT 2.08b / Capital Employed (Equity -1.44b + L.T.Debt 21.55b))
RoIC = 8.98% (NOPAT 2.06b / Invested Capital 22.89b)
WACC = 3.63% (E(39.36b)/V(68.93b) * Re(5.73%) + D(29.57b)/V(68.93b) * Rd(0.84%) * (1-Tc(0.01)))
Discount Rate = 5.73% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 81.65 | Cagr: 0.35%
[DCF] Terminal Value 87.09% ; FCFF base≈2.41b ; Y1≈2.61b ; Y5≈3.25b
[DCF] Fair Price = 152.9 (EV 95.98b - Net Debt 29.30b = Equity 66.69b / Shares 436.1m; r=5.90% [WACC]; 5y FCF grow 9.41% → 2.90% )
EPS Correlation: -36.83 | EPS CAGR: -10.87% | SUE: 0.02 | # QB: 0
Revenue Correlation: -78.06 | Revenue CAGR: -12.14% | SUE: 0.04 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.46 | Chg7d=+0.018 | Chg30d=+0.457 | Revisions Net=+1 | Analysts=4
EPS current Year (2026-12-31): EPS=2.35 | Chg7d=-0.008 | Chg30d=-1.055 | Revisions Net=-3 | Growth EPS=-6.6% | Growth Revenue=-5.2%
EPS next Year (2027-12-31): EPS=2.80 | Chg7d=-1.002 | Chg30d=-1.177 | Revisions Net=-3 | Growth EPS=+19.0% | Growth Revenue=+1.5%
[Analyst] Revisions Ratio: +1.00 (1 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 5.1% (Discount Rate 7.9% - Earnings Yield 2.8%)
[Growth] Growth Spread = -11.6% (Analyst -6.5% - Implied 5.1%)